Sam Rasehlo


Africa Health Research Institute (AHRI), Durban, South Africa


Transcriptional heterogeneity of B cells and the impact on antibody responses in HIV

Collaboration Interests
  • HIV Vaccine Development/Discovery

Sam Rasehlo was born in Limpopo province, South Africa. He holds a Master’s degree in Medical Microbiology from the University of Pretoria in Gauteng, South Africa. He is interested in studying B cell responses in HIV and determining the features of B cells that produce broadly neutralising antibodies (bNabs). Determining if the B cells that produce bNabs have special favourable features will guide the development of vaccination formulations that have a likelihood of inducing similar antibodies.

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.